115 related articles for article (PubMed ID: 34019907)
1. Knockdown of NLE1 inhibits development of malignant melanoma in vitro and in vivo NLE1 promotes development of malignant melanoma.
Ren Z; Ni F; Zhang T; Yuan X; Li J; Xiao W
Exp Cell Res; 2021 Jul; 404(2):112636. PubMed ID: 34019907
[TBL] [Abstract][Full Text] [Related]
2. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
Gao H; Liu R; Sun X
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
[TBL] [Abstract][Full Text] [Related]
4. DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis.
Xu Y; Sun W; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Chen Y
Exp Cell Res; 2019 Jun; 379(1):48-54. PubMed ID: 30880030
[TBL] [Abstract][Full Text] [Related]
5. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
Oliveira CS; de Bock CE; Molloy TJ; Sadeqzadeh E; Geng XY; Hersey P; Zhang XD; Thorne RF
BMC Cancer; 2014 Aug; 14():630. PubMed ID: 25168062
[TBL] [Abstract][Full Text] [Related]
7. EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle.
Zheng W; Li Y; Su Z; Zhang J; Shi F; Liang W
Exp Cell Res; 2021 May; 402(1):112488. PubMed ID: 33508274
[TBL] [Abstract][Full Text] [Related]
8. NCAM regulates the proliferation, apoptosis, autophagy, EMT, and migration of human melanoma cells via the Src/Akt/mTOR/cofilin signaling pathway.
Li J; Yang R; Yang H; Chen S; Wang L; Li M; Yang S; Feng Z; Bi J
J Cell Biochem; 2020 Feb; 121(2):1192-1204. PubMed ID: 31468584
[TBL] [Abstract][Full Text] [Related]
9. Matrin-3 plays an important role in cell cycle and apoptosis for survival in malignant melanoma.
Kuriyama H; Fukushima S; Kimura T; Okada E; Ishibashi T; Mizuhashi S; Kanemaru H; Kajihara I; Makino K; Miyashita A; Aoi J; Okada S; Ihn H; Kita K
J Dermatol Sci; 2020 Nov; 100(2):110-119. PubMed ID: 32943284
[TBL] [Abstract][Full Text] [Related]
10. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
11. Declination of long noncoding RNA paternally expressed gene 10 inhibits A375 cells proliferation, migration, and invasion via mediating microRNA-33a.
Fu Y; Bi Y; Wang F; Chen X; Liu H
J Cell Biochem; 2019 Dec; 120(12):19868-19877. PubMed ID: 31318088
[TBL] [Abstract][Full Text] [Related]
12. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway.
Long J; Pi X
Biomed Res Int; 2020; 2020():5149417. PubMed ID: 32733943
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
14. SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis.
Loevenich LP; Tschurtschenthaler M; Rokavec M; Silva MG; Jesinghaus M; Kirchner T; Klauschen F; Saur D; Neumann J; Hermeking H; Jung P
Cancer Res; 2022 Dec; 82(24):4604-4623. PubMed ID: 36219392
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway.
Meng F; Zhang Y; Li X; Wang J; Wang Z
Oncol Rep; 2017 Sep; 38(3):1655-1662. PubMed ID: 28731179
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway.
Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z
J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042
[TBL] [Abstract][Full Text] [Related]
17. PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.
Ye Y; Jin L; Wilmott JS; Hu WL; Yosufi B; Thorne RF; Liu T; Rizos H; Yan XG; Dong L; Tay KH; Tseng HY; Guo ST; de Bock CE; Jiang CC; Wang CY; Wu M; Zhang LJ; Hersey P; Scolyer RA; Zhang XD
Nat Commun; 2013; 4():1508. PubMed ID: 23443536
[TBL] [Abstract][Full Text] [Related]
18. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
19. RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression.
Yi M; Yang J; Chen X; Li J; Li X; Wang L; Tan Y; Xiong W; Zhou M; McCarthy JB; Li G; Xiang B; Xie H
J Cell Physiol; 2011 Sep; 226(9):2360-9. PubMed ID: 21660959
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R.
Yang C; Xia Z; Zhu L; Li Y; Zheng Z; Liang J; Wu L
Cell Cycle; 2019 Dec; 18(24):3513-3524. PubMed ID: 31724454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
